Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
News
 
Recent Executive Moves 12/13/2019
BeiGene Announces Clinical Data on Anti-PD-1 Tislelizumab in Comb... 12/13/2019
ZJ Medicine and Ambrx Present Positive Data from a Phase 1a/1b Tr... 12/13/2019
Granules to Dispose Full Stake in Chinese JV 12/13/2019
NMPA and NHC Issues Joint Notice for Vaccine IT Tracing Infrastru... 12/13/2019
Preview of 16 Heavy-weight New Drug Expected to be Approved in Ch... 12/13/2019
IQVIA: Chinese Hospital Drug Market Up 9.7% in MAT Q3/2019 12/13/2019
IQVIA: Chinese Retail Pharmacy Sales Up 1.9% in Q3/2019 12/13/2019
ChP Commission Solicits Comments on the draft of “Naming Princip... 12/12/2019
Eli Lilly's Verzenio and Amgen's Blincyto To Be Granted Priority ... 12/12/2019
Upcoming Event: International Conference on Biosimilars and Biolo... (free) 12/12/2019
Numab and 3SBio's Subsidiary Form Partnership to Develop Novel Mu... 12/12/2019
NMPA Issues the Guidelines for Aluminum Adjuvant in Preventative ... 12/12/2019
AstraZeneca Granted Chinese Approval of Imfinziin for Unresectabl... 12/12/2019
Avantor Opens Center in Shanghai to Boost Biopharma Innovation in... 12/11/2019
Harbin Pharmaceutical Group Poised to Take Over Ailing GNC (free) 12/11/2019
Private Investigator Couple Sue GSK for Misleading Work in China 12/11/2019
National Drug Usage Monitoring Platform Becomes Operational 12/10/2019
SAMR Solicits Public Comments on the Provisions for Registration ... 12/10/2019
CStone's anti-PD-L1 antibody Demonstrates Promising Antitumor Act... 12/10/2019
PingAn Good Doctor and Merck Sign Agreement to Explore Integrated... 12/9/2019
Samsung Bioepis Approved to Initiate Phase 3 Trial of Trastuzumab... 12/9/2019
Joinn Bio Raises $60M in Round A Financing 12/9/2019
NHSA issues New Policy for Drug Price Regulation 12/6/2019
Recent Executive Moves 12/6/2019
Innovent Announces First Patient Dosed in Phase I Trial of Anti-L... 12/6/2019
Amgen's IND for Osteoporosis Drug Romosozumab Approved in China 12/5/2019
XiAn Janssen's Application for 2nd Indication of Erleada Accepted... 12/5/2019
Interpace Bio Expands Strategic Partnership with Genecast in Chin... (free) 12/5/2019
AstraZeneca-Merck Lynparza Approved in China for Ovarian Cancer 12/5/2019
Page:1/40    Total number of articles:1179  :[1][2][3][4][5][>>][End]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links